154 related articles for article (PubMed ID: 31356175)
1. B Cell-Mediated Antigen Presentation through MHC Class II Is Dispensable for Atherosclerosis Progression.
Williams JW; Elvington A; Kessler S; Wohltmann M; Wu GF; Randolph GJ
Immunohorizons; 2019 Jan; 3(1):37-44. PubMed ID: 31356175
[TBL] [Abstract][Full Text] [Related]
2. Follicular B Cells Promote Atherosclerosis via T Cell-Mediated Differentiation Into Plasma Cells and Secreting Pathogenic Immunoglobulin G.
Tay C; Liu YH; Kanellakis P; Kallies A; Li Y; Cao A; Hosseini H; Tipping P; Toh BH; Bobik A; Kyaw T
Arterioscler Thromb Vasc Biol; 2018 May; 38(5):e71-e84. PubMed ID: 29599140
[TBL] [Abstract][Full Text] [Related]
3. B Cell-Specific MHC Class II Deletion Reveals Multiple Nonredundant Roles for B Cell Antigen Presentation in Murine Lupus.
Giles JR; Kashgarian M; Koni PA; Shlomchik MJ
J Immunol; 2015 Sep; 195(6):2571-9. PubMed ID: 26268653
[TBL] [Abstract][Full Text] [Related]
4. LAMP-2-deficient human B cells exhibit altered MHC class II presentation of exogenous antigens.
Crotzer VL; Glosson N; Zhou D; Nishino I; Blum JS
Immunology; 2010 Nov; 131(3):318-30. PubMed ID: 20518820
[TBL] [Abstract][Full Text] [Related]
5. Transient T and B cell activation after neonatal induction of tolerance to MHC class II or Mls alloantigens.
Schurmans S; Brighouse G; Kramer G; Wen L; Izui S; Merino J; Lambert PH
J Immunol; 1991 Apr; 146(7):2152-60. PubMed ID: 1672344
[TBL] [Abstract][Full Text] [Related]
6. Studying MHC Class II Presentation of Immobilized Antigen by B Lymphocytes.
Sáez JJ; Lennon-Duménil AM; Yuseff MI
Methods Mol Biol; 2019; 1988():419-437. PubMed ID: 31147956
[TBL] [Abstract][Full Text] [Related]
7. The actin-based motor protein myosin II regulates MHC class II trafficking and BCR-driven antigen presentation.
Vascotto F; Lankar D; Faure-André G; Vargas P; Diaz J; Le Roux D; Yuseff MI; Sibarita JB; Boes M; Raposo G; Mougneau E; Glaichenhaus N; Bonnerot C; Manoury B; Lennon-Duménil AM
J Cell Biol; 2007 Mar; 176(7):1007-19. PubMed ID: 17389233
[TBL] [Abstract][Full Text] [Related]
8. MHC class II cell-autonomously regulates self-renewal and differentiation of normal and malignant B cells.
Merkenschlager J; Eksmond U; Danelli L; Attig J; Young GR; Nowosad C; Tolar P; Kassiotis G
Blood; 2019 Mar; 133(10):1108-1118. PubMed ID: 30700420
[TBL] [Abstract][Full Text] [Related]
9. Dendritic cells, but not macrophages or B cells, activate major histocompatibility complex class II-restricted CD4+ T cells upon immune-complex uptake in vivo.
de Jong JM; Schuurhuis DH; Ioan-Facsinay A; Welling MM; Camps MG; van der Voort EI; Huizinga TW; Ossendorp F; Verbeek JS; Toes RE
Immunology; 2006 Dec; 119(4):499-506. PubMed ID: 16995881
[TBL] [Abstract][Full Text] [Related]
10. CD40-induced aggregation of MHC class II and CD80 on the cell surface leads to an early enhancement in antigen presentation.
Clatza A; Bonifaz LC; Vignali DA; Moreno J
J Immunol; 2003 Dec; 171(12):6478-87. PubMed ID: 14662847
[TBL] [Abstract][Full Text] [Related]
11. SYK regulates macrophage MHC-II expression via activation of autophagy in response to oxidized LDL.
Choi SH; Gonen A; Diehl CJ; Kim J; Almazan F; Witztum JL; Miller YI
Autophagy; 2015; 11(5):785-95. PubMed ID: 25946330
[TBL] [Abstract][Full Text] [Related]
12. Disruption of multivesicular body vesicles does not affect major histocompatibility complex (MHC) class II-peptide complex formation and antigen presentation by dendritic cells.
Bosch B; Berger AC; Khandelwal S; Heipertz EL; Scharf B; Santambrogio L; Roche PA
J Biol Chem; 2013 Aug; 288(34):24286-92. PubMed ID: 23846690
[TBL] [Abstract][Full Text] [Related]
13. Cutting edge: Conditional MHC class II expression reveals a limited role for B cell antigen presentation in primary and secondary CD4 T cell responses.
Archambault AS; Carrero JA; Barnett LG; McGee NG; Sim J; Wright JO; Raabe T; Chen P; Ding H; Allenspach EJ; Dragatsis I; Laufer TM; Wu GF
J Immunol; 2013 Jul; 191(2):545-50. PubMed ID: 23772037
[TBL] [Abstract][Full Text] [Related]
14. Two levels of help for B cell alloantibody production.
Steele DJ; Laufer TM; Smiley ST; Ando Y; Grusby MJ; Glimcher LH; Auchincloss H
J Exp Med; 1996 Feb; 183(2):699-703. PubMed ID: 8627185
[TBL] [Abstract][Full Text] [Related]
15. MHC Class II-restricted antigen presentation by plasmacytoid dendritic cells drives proatherogenic T cell immunity.
Sage AP; Murphy D; Maffia P; Masters LM; Sabir SR; Baker LL; Cambrook H; Finigan AJ; Ait-Oufella H; Grassia G; Harrison JE; Ludewig B; Reith W; Hansson GK; Reizis B; Hugues S; Mallat Z
Circulation; 2014 Oct; 130(16):1363-73. PubMed ID: 25223984
[TBL] [Abstract][Full Text] [Related]
16. The pathway of antigen uptake and processing dictates MHC class II-mediated B cell survival and activation.
Nashar TO; Drake JR
J Immunol; 2005 Feb; 174(3):1306-16. PubMed ID: 15661887
[TBL] [Abstract][Full Text] [Related]
17. Role of MHC class II on memory B cells in post-germinal center B cell homeostasis and memory response.
Shimoda M; Li T; Pihkala JP; Koni PA
J Immunol; 2006 Feb; 176(4):2122-33. PubMed ID: 16455968
[TBL] [Abstract][Full Text] [Related]
18. Germinal Center-Derived Antibodies Promote Atherosclerosis Plaque Size and Stability.
Centa M; Jin H; Hofste L; Hellberg S; Busch A; Baumgartner R; Verzaal NJ; Lind Enoksson S; Perisic Matic L; Boddul SV; Atzler D; Li DY; Sun C; Hansson GK; Ketelhuth DFJ; Hedin U; Wermeling F; Lutgens E; Binder CJ; Maegdesfessel L; Malin SG
Circulation; 2019 May; 139(21):2466-2482. PubMed ID: 30894016
[TBL] [Abstract][Full Text] [Related]
19. Tumor-specific CD4+ T cells are activated by "cross-dressed" dendritic cells presenting peptide-MHC class II complexes acquired from cell-based cancer vaccines.
Dolan BP; Gibbs KD; Ostrand-Rosenberg S
J Immunol; 2006 Feb; 176(3):1447-55. PubMed ID: 16424172
[TBL] [Abstract][Full Text] [Related]
20. Atheroprotective vaccination with MHC-II-restricted ApoB peptides induces peritoneal IL-10-producing CD4 T cells.
Kimura T; Tse K; McArdle S; Gerhardt T; Miller J; Mikulski Z; Sidney J; Sette A; Wolf D; Ley K
Am J Physiol Heart Circ Physiol; 2017 Apr; 312(4):H781-H790. PubMed ID: 28087520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
